Publication Beamlines Strategic Pillar
Jenkins, Meredith L.; Margaria, Jean Piero; Stariha, Jordan T. B.; Hoffmann, Reece M.; McPhail, Jacob A. et al. (2018). Structural determinants of Rab11 activation by the guanine nucleotide exchange factor SH3BP5. Nature Communications 9(1) . 10.1038/s41467-018-06196-z. [PDB: 6djl] CMCF-ID Health
Jha, Vikash; Ling, Hong (2018). Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender. Journal of Molecular Biology 430(11) , 1577-1589. 10.1016/j.jmb.2018.04.023. [PDB: 6brx, 6bs1] CMCF-ID Health
Jiang, Yingying; Tan, Shuo; Hu, Jianping; Chen, Xin; Chen, Feng et al. (2021). Amorphous calcium magnesium phosphate nanocomposites with superior osteogenic activity for bone regeneration. Regenerative Biomaterials 8(6) , rbab068. 10.1093/rb/rbab068. SXRMB Health
Jiang, Ying-Ying; Wang, Zhi-Qiang; Chen, Jia-Tang; Li, Jun; Zhu, Ying-Jie et al. (2020). Tracking the interaction of drug molecules with individual mesoporous amorphous calcium phosphate/ATP nanocomposites – an X-ray spectromicroscopy study. Physical Chemistry Chemical Physics 22(23) . 10.1039/d0cp00797h. SGM, SM, SXRMB, VLS-PGM Health
Jiang, Ying-Ying; Wang, Zhi-Qiang; Chen, Jia-Tang; Li, Jun; Zhu, Ying-Jie et al. (2020). Tracking the interaction of drug molecules with individual mesoporous amorphous calcium phosphate/ATP nanocomposites – an X-ray spectromicroscopy study. Physical Chemistry Chemical Physics 22(23) . 10.1039/d0cp00797h. SGM, SM, SXRMB, VLS-PGM Health
Jiang, Ying-Ying; Wang, Zhi-Qiang; Chen, Jia-Tang; Li, Jun; Zhu, Ying-Jie et al. (2020). Tracking the interaction of drug molecules with individual mesoporous amorphous calcium phosphate/ATP nanocomposites – an X-ray spectromicroscopy study. Physical Chemistry Chemical Physics 22(23) . 10.1039/d0cp00797h. SGM, SM, SXRMB, VLS-PGM Health
Jiang, Ying-Ying; Wang, Zhi-Qiang; Chen, Jia-Tang; Li, Jun; Zhu, Ying-Jie et al. (2020). Tracking the interaction of drug molecules with individual mesoporous amorphous calcium phosphate/ATP nanocomposites – an X-ray spectromicroscopy study. Physical Chemistry Chemical Physics 22(23) . 10.1039/d0cp00797h. SGM, SM, SXRMB, VLS-PGM Health
Jones, Carys S.; Sychantha, David; Howell, P. Lynne; Clarke, Anthony J. (2020). Structural basis for the O-acetyltransferase function of the extracytoplasmic domain of OatA from Staphylococcus aureus. Journal of Biological Chemistry 295(24) , jbc.RA120.013108. 10.1074/jbc.ra120.013108. [PDB: 6wn9] CMCF-BM Health
Jones, Darryl R.; McLean, Richard; Hobbs, Joanne K.; Abbott, D. Wade (2019). A surrogate structural platform informed by ancestral reconstruction and resurrection of a putative carbohydrate binding module hybrid illuminates the neofunctionalization of a pectate lyase. Journal of Structural Biology 207(3) , 279-286. 10.1016/j.jsb.2019.06.003. [PDB: 6ojk, 6ojl] CMCF-ID Health
Juvvadi, Praveen R.; Fox, David; Bobay, Benjamin G.; Hoy, Michael J.; Gobeil, Sophie M. C. et al. (2019). Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents. Nature Communications 10(1) . 10.1038/s41467-019-12199-1. [PDB: 6tz7] CMCF-ID Health
Kaasalainen, Martti; Zhang, Ran; Vashisth, Priya; Birjandi, Anahid Ahmadi; S’Ari, Mark et al. (2024). Lithiated porous silicon nanowires stimulate periodontal regeneration. Nature Communications 15(1) . 10.1038/s41467-023-44581-5. VLS-PGM Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl. Powder Diffraction , 1-7. 10.1017/s0885715624000496. BXDS-WLE Health